HomepageBlogEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine Blog IndustryEvonik Plans Further Investment in mRNA Field to Expand Applications Beyond COVID-19 Vaccine admin Posted on August 14, 2023 Evonik Industries AG supplies lipids essential to production of the Pfizer–BioNTech COVID-19 vaccine, in which messenger RNA (mRNA) is enclosed……Please subscribe to read the full story.Author admin View all posts Post navigationPrevious PostMitsubishi Chemical to Mass-Produce GaN Substrates for More Energy-Efficient Vehicles, Devices Next PostJSR to Boost Production Capacity for Advanced Semiconductor PhotoresistsYou Might Also Like BlogMitsui Chemicals Places Heightened Emphasis on Medical Sector admin August 14, 2023 BlogHazardous Chemical Substances: Understanding Risks and Safety Measures admin September 18, 2023 BlogMitsubishi Chemical Turns to AI in Bid to Prevent Risks From Facility Amendments admin August 14, 2023 BlogChamomile Tea: A Natural Remedy for Stress and Insomnia Bagus Saputra July 12, 2024
BlogMitsubishi Chemical Turns to AI in Bid to Prevent Risks From Facility Amendments admin August 14, 2023